Cameron Paul Simmons

Cameron Paul Simmons

Auto-generated profile, based on publicly available information

Cameron Paul Simmons

Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2013 in Nature
Verified
Journal Article
Open access
PDF file
SBSamir Bhatt
Samir Bhatt
PGPeter W. Gething
Peter W. Gething
OBOliver J. Brady
Oliver J. Brady
JMJane P. Messina
Jane P. Messina
AFAndrew W. Farlow
Andrew W. Farlow
SHSimon Hay
Simon Hay
The public health burden of dengue is unknown; here cartographic approaches are used to provide insight into the global, regional and national burden of dengue, with the finding that the global number of infections per year is around 390 million, more than three times the estimate of the World Health Organization. The mosquito-borne viral infection dengue is found in tropical and subtropical regions worldwide, predominantly in urban and semi-urban areas. The incidence of dengue is on the increase, but the current global distribution is poorly known. Simon Hay and colleagues have applied novel mapping techniques to an extensive evidence base of nearly 10,000 case records. The outcome is an estimate of around 390 million new infections per year, more than double the most recent estimate from the World Health Organization. Importantly, this work extends the mapping to provide global estimates of the symptomatic and asymptomatic dengue case burden, at 96 and 294 million, respectively. Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes1. For some patients, dengue is a life-threatening illness2. There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread3. The contemporary worldwide distribution of the risk of dengue virus infection4 and its public health burden are poorly known2,5. Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanization. Using cartographic approaches, we estimate there to be 390 million (95% credible interval 284–528) dengue infections per year, of which 96 million (67–136) manifest apparently (any level of disease severity). This infection total is more than three times the dengue burden estimate of the World Health Organization2. Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.

1 December 2010 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
MGMaria G. Guzman
Maria G. Guzman
SHScott B. Halstead
Scott B. Halstead
HAHarvey Artsob
Harvey Artsob
PBPhilippe Buchy
Philippe Buchy
JFJeremy Farrar
Jeremy Farrar
RPRosanna Peeling
Rosanna Peeling

12 April 2012 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
CSCameron P. Simmons
Cameron P. Simmons
JFJeremy J. Farrar
Jeremy J. Farrar
NCNguyen van Vinh Chau
Nguyen van Vinh Chau
BWBridget Wills
Bridget Wills
Dengue is a self-limited, systemic viral infection transmitted between humans by mosquitoes. The rapidly expanding global footprint of dengue is a public health challenge with an economic burden that is currently unmet by licensed vaccines, specific therapeutic agents, or efficient vector-control strategies. This review highlights our current understanding of dengue, including its clinical manifestations, pathogenesis, tests that are used to diagnose it, and its management and prevention.

10 September 2006 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MJMenno D de Jong
Menno D de Jong
CSCameron P Simmons
Cameron P Simmons
TTTran Tan Thanh
Tran Tan Thanh
VHVo Minh Hien
Vo Minh Hien
GSGavin Smith
Gavin Smith
JFJeremy Farrar
Jeremy Farrar

1 March 2012 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
JTJennifer R. Tisoncik
Jennifer R. Tisoncik
MKMarcus J. Korth
Marcus J. Korth
CSCameron P. Simmons
Cameron P. Simmons
JFJeremy Farrar
Jeremy Farrar
TMThomas R. Martin
Thomas R. Martin
MKMichael G. Katze
Michael G. Katze
SUMMARY: The cytokine storm has captured the attention of the public and the scientific community alike, and while the general notion of an excessive or uncontrolled release of proinflammatory cytokines is well known, the concept of a cytokine storm and the biological consequences of cytokine overproduction are not clearly defined. Cytokine storms are associated with a wide variety of infectious and noninfectious diseases. The term was popularized largely in the context of avian H5N1 influenza virus infection, bringing the term into popular media. In this review, we focus on the cytokine storm in the context of virus infection, and we highlight how high-throughput genomic methods are revealing the importance of the kinetics of cytokine gene expression and the remarkable degree of redundancy and overlap in cytokine signaling. We also address evidence for and against the role of the cytokine storm in the pathology of clinical and infectious disease and discuss why it has been so difficult to use knowledge of the cytokine storm and immunomodulatory therapies to improve the clinical outcomes for patients with severe acute infections.

19 August 2016 in Science
Verified
Journal Article
Closed access
PDF file
KSKarin Stettler
Karin Stettler
MBMartina Beltramello
Martina Beltramello
DEDiego A. Espinosa
Diego A. Espinosa
VGVictoria Graham
Victoria Graham
ACAntonino Cassotta
Antonino Cassotta
DCDavide Corti
Davide Corti
Characterizing the Zika virus antibody response: Given the public health emergency that Zika virus poses, scientists are seeking to understand the Zika-specific immune response. Stettler et al. analyzed 119 monoclonal antibodies isolated from four donors that were infected with Zika virus during the present epidemic, including two individuals that had previously been infected with dengue virus, another member of the flavivirus family. Neutralizing antibodies primarily recognized the envelope protein domain III (EDIII) or quaternary epitopes on the intact virus, and an EDIII-targeted antibody protected mice against lethal infection. Some EDI/II-targeting antibodies cross-reacted with dengue virus in vitro and could enhance disease in dengue-infected mice. Whether dengue and Zika virus antibodies cross-react in humans remains to be tested. Science , this issue p. 823